the research network is therefore investigating in a clinical trial how the BDNF marker as a blood test can improve the care of depressed people. In addition, further new biomarkers are to be identified [...] Hanover, Kiel, Greifswald, Würzburg and Frankfurt. The study is characterised by the fact that the test persons are comprehensively examined and very different parameters are recorded. "We collect findings

problem with conventional blood products is possible pathogens, as blood cannot be tested for all pathogens and, moreover, all test methods have a detection limit. Unlimited production in the bioreactor "The

Pediatric Pneumology, Allergology and Neonatology. As part of the experimental research project, he tested novel gene ferries. In doing so, he successfully demonstrated the correction of the IFN-γR1 signaling [...] deficiency. In Professor Lachmann's research group, gene shuttles were successfully developed, which were tested for their function by Liart Pollmann. He successfully introduced the missing gene into target cells

examined," adds Dr Hauke Thiesler from Professor Hildebrandt's research group. "A simple genetic test in combination with other factors could enable a more precise individual prognosis." Furthermore,

process: Overall grade of university entrance qualification with a weighting of 30 percent, result of the Test for Medical Studies (TMS) with a weighting of 30 percent, and periods of relevant vocational training

drug The FIBREX project is now the logical continuation of the research work. "We are now further testing the Meg3 inhibitor in animal models for efficacy safety in order to reach clinical maturity," explains

in diseased lung tissue, but not in healthy lungs. He now wants to use the new methods to find and test biomarkers for the early detection of lung diseases, the assessment of disease progression and new

only recommend infusions,” says Professor Kempf. In the pilot study ORION-HF, cardiologists are now testing an iron preparation that has already been approved for other diseases. The focus is on the group

extensive expertise in somatic cell reprogramming, genetic engineering, bioprocessing and preclinical testing, particularly in the areas of heart, liver and lung repair. The Else Kröner-Fresenius Foundation

application projects in the fields of genomics, diagnostics, prevention and treatment, we want to test what works, is clinically practicable and makes sense.” CAN.HEAL is also dedicated to ethical and